# OnCo record biodexa-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/biodexa-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "biodexa-pharmaceuticals" ;
  schema:name "Biodexa Pharmaceuticals"@en ;
  schema:alternateName "Biodexa Pharmaceuticals PLC"@en ;
  schema:description "Biodexa Pharmaceuticals is a Cardiff company developing eRapa, a new form of the drug rapamycin, in a large trial for an inherited condition that causes bowel polyps and cancer, and MTX240, an early drug for gastrointestinal stromal tumour."@en ;
  schema:url <https://onco.cc/companies/biodexa-pharmaceuticals/>, <https://www.biodexapharma.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1643918/000121465926011934/y917262f1.htm>, <https://www.biodexapharma.com/> ;
  schema:addressCountry "GB" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/prevention/> ;
  onco:targets <https://onco.cc/targets/mtor/>, <https://onco.cc/targets/kit/> ;
  onco:drugs <https://onco.cc/drugs/erapa/>, <https://onco.cc/drugs/mtx240/> .